Skip to main content

and
  1. No Access

    Article

    Effectiveness of Trimetazidine in Patients with Chronic Heart Failure Stratified by the Expression of Soluble Suppression of Tumorigenicity-2 (sST2): A Prospective Cohort Study

    Trimetazidine has been reported to have potential benefits in patients with chronic heart failure (CHF). Soluble suppression of tumorigenicity-2 (sST2) was shown to worsen CHF and, hence, has a diagnostic valu...

    Zhu Min, Liu Xuelu, Zhang Ran, Shu Qiuhong, Meng Yong in Advances in Therapy (2022)